Table 1.
Resistance profile | N° of isolates | % Isolates | N° of patients | % Patients | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PEN | OXA | – | TOB | – | – | – | – | – | – | – | – | 1 | 6.7 | 1 | 6.7 |
PEN | OXA | – | – | LVX | MFX | – | – | – | – | – | – | 1 | 6.7 | 1 | 6.7 |
PEN | OXA | GEN | TOB | – | – | – | – | – | – | – | – | 1 | 6.7 | 1 | 6.7 |
PEN | OXA | GEN | TOB | LVX | MFX | – | – | TCY | FUS | – | RIF | 1 | 6.7 | 1 | 6.7 |
PEN | OXA | GEN | TOB | LVX | MFX | ERY | CLI | TCY | – | – | RIF | 7 | 46.7 | 7 | 46.7 |
PEN | OXA | GEN | TOB | LVX | MFX | ERY | CLI | TCY | – | FOS | RIF | 4 | 26.7 | 4 | 26.7 |
Abbreviations: PEN penicillin G, OXA oxacillin, GEN gentamicin, TOB tobramycin, LVX levofloxacin, MFX moxifloxacin, ERY erythromycin, CLI clindamycin, TCY tetracycline, FUS fusidic acid, FOS fosfomycin, RIF rifampicin